Serious Consequences to the Use of Cephalosporins as the First Line of Antimicrobial Therapy Administered in Hemodialysis Units

Vol. 101, No. 2, 2005

Free Abstract Article (Fulltext) Article (PDF 116 KB)

Original Paper

Serious Consequences to the Use of Cephalosporins as the First Line of Antimicrobial Therapy Administered in Hemodialysis Units
Dror Marchaim^a, Zipora Lazarovitch^b, Shai Efrati^a, Victor Dishy^{a, c}, Joshua Weissgarten^c, Ida Boldur^b, Ronit Zaidenstein^a

Departments of
^aMedicine 'A',
^bMicrobiology and
^cNephrology, Asaf-Harofe Medical Center, affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Zerifin, Israel

Address of Corresponding Author

Nephron Clin Pract 2005;101:c58-c64 (DOI: 10.1159/000086223)

Key Words

Extended-spectrum -lactamase
-Lactamase
Cephalosporins
Hemodialysis, Israel

Abstract

Background: The dramatic spread of vancomycin-resistant enterococci (VRE) among hemodialysis (HD) patients led to the replacement of vancomycin with cephalosporins as part of the primary empiric therapy for bacterial infections in HD units. The aim of the study was to examine the effects of this new regimen on the colonization rate of resistant bacteria among HD patients. Methods: Rectal swabs were taken from 105 HD patients and 91 control hospitalized patients. Groups were matched for age, sex, nursing home residency and background diseases. Enterococci were tested for vancomycin resistance, Staphylococcus aureus isolates were tested for methicillin resistance (MRSA), and Enterobacteriaceae were tested for extended-spectrum beta -lactamase (ESBL) activity. Results: In the HD group 1 VRE, 1 MRSA and 9 ESBL-producing organisms were isolated compared to 1 MRSA and 1 ESBL organism in the control group (p = 0.018 for ESBL). In the year prior to the study, the use of cephalosporins had been enhanced in the HD group compared to the control group (p < 0.001), and in the HD ESBL-positive patients compared to the HD ESBL-negative ones (p = 0.007). The overall use of antibiotics in the control group was the same as in the HD group. In a subanalysis of the HD group alone, the ESBL carriers were older, sicker, used more antibiotics, were hospitalized frequently and had a higher mortality rate, compared to noncarriers. Conclusions: The use of cephalosporins as first-line therapy in HD patients in central Israel reduced the prevalence of VRE colonization but may have contributed to the emergence of ESBL-producing organisms through induction of selection pressure. This may lead to serious complications in the management of these patients.

Author Contacts

Dror Marchaim, MD
Department of Medicine 'A'
Asaf-Harofeh Medical Center
Zerifin 70300 (Israel)
Tel. +972 8 9779243, Fax +972 8 9778359, E-Mail drormc@netvision.net.il

Article Information

Received: December 8, 2004
Accepted: February 17, 2005
Published online: June 7, 2005
Number of Print Pages : 7
Number of Figures : 0, Number of Tables : 5, Number of References : 20

Medline Abstract (ID 15942252)

Download Citation

Cited In

For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their research paper editing service.